Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Respiratory pathology associated with pneumococcus].

Paul Léophonte1

  • 1Service de Pneumologie, Hôpital Rangueil, TSA 50032, 31059 Toulouse.

Bulletin De L'Academie Nationale De Medecine
|April 3, 2003
PubMed
Summary

Pneumococcal pneumonia, a leading infectious disease killer, is increasingly challenging due to antibiotic resistance. Vaccination is crucial for prevention, especially in vulnerable populations, yet remains underutilized.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[3<sup>e</sup> Conférence européenne sur la grippe, et XXI<sup>es</sup> Rencontres européennes de prévention et contrôle de la grippe].

Virologie (Montrouge, France)·2022
Same author

Efficiency of a phone coaching program on adherence to continuous positive airway pressure in sleep apnea hypopnea syndrome: a randomized trial.

BMC pulmonary medicine·2015
Same author

[Sleep apnea syndromes and cardiovascular disease].

Bulletin de l'Academie nationale de medecine·2005
Same author

[Antivirals for influenza].

Bulletin de l'Academie nationale de medecine·2005
Same author

[Infections in chronic obstructive pulmonery disease].

Bulletin de l'Academie nationale de medecine·2004
Same author

[Broncho-pulmonary infections in the adult].

La Revue du praticien·2004

Area of Science:

  • Infectious Diseases
  • Bacteriology
  • Public Health

Context:

  • Pneumococcal pneumonia is a significant cause of mortality in industrialized nations.
  • Rising antibiotic resistance, particularly to penicillin, poses a major public health threat.
  • Elderly individuals and those with comorbidities are at higher risk.

Purpose:

  • To review the epidemiology, clinical presentation, diagnosis, treatment, and prevention of pneumococcal pneumonia.
  • To highlight the challenges posed by antibiotic-resistant strains and the importance of vaccination.

Summary:

  • Pneumococcal pneumonia remains a leading infectious cause of death, with increasing antibiotic resistance complicating treatment.
  • Diagnosis involves traditional methods and newer antigen-detection tests. While resistance is a concern, outcomes are not significantly impacted.
  • Risk factors for resistant strains include young age, elderly status, and prior antibiotic exposure. Vaccination is a key preventive measure, particularly for high-risk groups.

Impact:

  • Highlights the critical need for improved pneumococcal vaccination rates, especially among the elderly and those with chronic conditions.
  • Underscores the public health challenge of antibiotic resistance in common bacterial infections.
  • Emphasizes the importance of timely diagnosis and appropriate treatment strategies for pneumococcal pneumonia.

Related Experiment Videos